SCHEMBL704604

SCHEMBL704604

CC(C)(C)[Si](F)(c1ccccc1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 3/20 0.32
TSHR P16473 2/20 0.32
TAAR1 Q96RJ0 2/20 0.31
ALOX15 P16050 1/20 0.31
SLC6A2 P23975 1/20 0.31
LMNA P02545 1/20 0.30
ALOX12 P18054 1/20 0.30
ACHE P22303 1/20 0.30
ATM Q13315 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13933322 1.00 NR1H2 (0.36) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL31463487 0.80
SCHEMBL702684 0.79 NR1H2 (0.36) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL707249 0.79 NR1H2 (0.36) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL8380445 0.74 ESR1 (0.34) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL20328588 0.72 ESR1 (0.37) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL3526796 0.72 ESR1 (0.37) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL29749402 0.72 ESR1 (0.37) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL3888384 0.72 ESR1 (0.37) NR1H2NR1H3ESR1ESR2MAPK1
SCHEMBL1314801 0.72 ESR1 (0.38) NR1H2NR1H3ESR1ESR2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174841-A1 Breakable Emulsifiers HALLIBURTON ENERGY SERVICES, INC. (US) 2023-06-08 US disclosed
CN-110483413-B Process for the preparation of carbocyclic sugar derivatives 百缮药业(苏州)有限公司 2023-02-28 CN disclosed
EP-4112604-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-1-((1S,4R,5S)-2-FLUORO-4,5-DIHIDROXY-3-HYDROXY-METHYL-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE Ocuphire Pharma, Inc. (US) 2023-01-04 EP disclosed
CN-107474034-B Process for the preparation of carbocyclic sugar derivatives 瑞沙恩医药公司 2020-06-30 CN disclosed
CN-110483413-A The method for being used to prepare carbocyclic ring sugar derivatives REXAHN PHARMACEUTICALS INC 2019-11-22 CN disclosed
US-10345701-B2 Photoresist polymers, photoresist compositions, methods of forming patterns and methods of manufacturing semiconductor devices SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-09 US disclosed
EP-3246320-B1 PROCESS FOR THE PREPARATION OF 4-AMINO-1-((1S,4R,5S)-2-FLUORO-4,5-DIHYDROXY-3- HYDROXYMETHYL-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE REXAHN PHARMACEUTICALS INC (US) 2019-05-08 EP disclosed
EP-3378855-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-1-((1S,4R,5S)-2-FLUORO-4,5-DIHIDROXY-3-HYDROXY-METHYL-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE Rexahn Pharmaceuticals, Inc. (US) 2018-09-26 EP disclosed
EP-2970147-B1 PROCESS FOR THE PREPARATION OF 4-AMINO-1-((1S,4R, 5S)-2-FLUORO-4,5-DIHYDROXY-3-HYDROXYMETHYL-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE REXAHN PHARMACEUTICALS INC (US) 2018-05-30 EP disclosed
US-9920016-B2 Process for the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one REXAHN PHARMACEUTICALS, INC. (US) 2018-03-20 US disclosed
US-20150376142-A1 Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-One Ocuphire Pharma, Inc. 2015-12-31 US disclosed
US-9150520-B2 Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one REXAHN PHARMACEUTICALS, INC. (US) 2015-10-06 US disclosed
US-20140275537-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-1-((1S,4R,5S)-2-FLUORO-4,5-DIHYDROXY-3-HYDROXYMETHYL-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE REXAHN PHARMACEUTICALS, INC. (US) 2014-09-18 US disclosed
US-8124239-B2 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2012-02-28 US disclosed
US-20100155121-A1 SILICA FILM FORMING MATERIAL, SILICA FILM AND METHOD OF MANUFACTURING THE SAME, MULTILAYER WIRING STRUCTURE AND METHOD OF MANUFACTURING THE SAME, AND SEMICONDUCTOR DEVICE AND METHOD OF MANUFACTURING THE SAME FUJITSU LIMITED (JP) 2010-06-24 US disclosed
US-7659357-B2 Precursor organosilicon polymer of 1,2-Bis(dimethylethoxysilyl)ethane, 1,4-bis(dimethylethoxysilyl)benzene, tetraethoxysilane, methyltriethoxysilane, phenyltriethoxysilane; dielectric (DE) films having etching/chemical/moisture resistance; adhesion; low DE constant; minimal wiring delay; high speed FUJITSU LIMITED (JP) 2010-02-09 US disclosed
US-20070026689-A1 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2007-02-01 US disclosed
US-6811822-B2 Method of waterproofing the surface of a polymer work piece Institut fur Mikrotechnik Mainz (DE) 2004-11-02 US disclosed
US-20030185992-A1 Method of waterproofing the surface of a polymer work piece INSTITUT FUR MIKROTECHNIK MAINZ GMBH (DE) 2003-10-02 US disclosed
US-4851417-A 9-substituted 6H-pyrido[4,3-b]carbazoles RENSSELAER POLYTECHNIC INSTITUTE (US) 1989-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376142-A1 Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-One RXFP4, RXFP1, NPY4R NR1H2 2093/4885NR1H3 1691/4885ESR1 2223/4885
US-20140275537-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-1-((1S,4R,5S)-2-FLUORO-4,5-DIHYDROXY-3-HYDROXYMETHYL-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE RXFP4, RXFP1, NPY4R NR1H2 1913/4885NR1H3 1534/4885ESR1 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.